Date: February 2024
The Department of Health and Aged care contacted the RACGP as we had previously provided input on MSAC application 1677 Pharmacy Diabetes Screening trial. Resubmission of this application is being considered at the upcoming MSAC meeting in April 2024.
The RACGP supports efforts to improve the identification and management of people with diabetes. However, as detailed in our previous feedback, the RACGP has serious concerns with the evidence-base underpinning the screening protocol in this pharmacy trial and the potential for the model to fragment patient care and reduce the comprehensiveness of care.
RACGP submission - MSAC 1677.1 Pharmacy diabetes screening trial (PDF)
Appendix Two - 1677 Public Summary Document (PDF)
Appendix Three - RACGP response MSAC Pharma (PDF)